Dapsone
- Product NDC
- 83209-566
- 11-digit product format
- 832090566
- Labeler code
- 83209
- Product ID
- 83209-566_20e8edf4-4458-c1da-e063-6394a90aa891
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Boswell Pharmacy Services LLC d/b/a BPS Wholesale
- Application
- ANDA207165
- Marketing category
- ANDA
- Marketing start
- 2024-08-30
- Substance
- DAPSONE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Sulfone [EPC], Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dapsone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DAPSONE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8W5C518302 |
| Rxcui | 197557 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 83209-566-30 | Dapsone | 30 in 1 BLISTER PACK | TABLET | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 83209-566-30 | 83209056630 | 30 TABLET in 1 BLISTER PACK (83209-566-30) | 30 tablet | 2024-08-30 | No | No | Historical |